1983
DOI: 10.1016/0303-7207(83)90097-7
|View full text |Cite
|
Sign up to set email alerts
|

Peptides of the neurointermediary lobe of rat pituitary stimulate GH secretion in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1986
1986
1988
1988

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…Interestingly, this a-MSH inhibitor has been previously described in the literature as a growth hormone-releasing peptide in vitro and in vivo (Bowers et al, 1984). Furthermore, it is known that a-MSH peptides possess weak growth hormone-releasing properties (Schlegel et al, 1983). Thus, the exact interrelationship of a-MSH and its analogs on pituitary function as related to growth hormone secretion remains unclear.…”
Section: A-msh Antagonist Analoguesmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, this a-MSH inhibitor has been previously described in the literature as a growth hormone-releasing peptide in vitro and in vivo (Bowers et al, 1984). Furthermore, it is known that a-MSH peptides possess weak growth hormone-releasing properties (Schlegel et al, 1983). Thus, the exact interrelationship of a-MSH and its analogs on pituitary function as related to growth hormone secretion remains unclear.…”
Section: A-msh Antagonist Analoguesmentioning
confidence: 99%
“…In fact, the excess secretion of ACTH, as in Addison's disease, can result in the hyperpigmentation of human skin, because of the intrinsic melanotropic activity of this peptide (Hadley, 1984). Finally, it is not known whether any physiological processes are controlled by 0-MSH or y-MSH, two other POMC-derived members of the so-called melanocortin de Wied and Jolles, 1982;Gispen et al, 1975;Hadley, 1984;Hadley et al, 1986;Hruby et al, 1984;Kokobun et al, 1983;Murphy et al, 1983;O'Donohue and Dorsa, 1982;Schlegel et al, 1983;Strand and Smith, 1980;Tatro and Reichlin, 1987;van Nispen and Greven, 1982). However, a definitive evaluation of the specificity of these biological effects has not included comparative structure-activity analysis, radioreceptor testing, or inhibition by the use of a n a-MSH antagonist.…”
Section: Introductionmentioning
confidence: 99%